BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7914453)

  • 41. The pharmacoeconomics of cancer therapies.
    Bishop JF; Macarounas-Kirchman K
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-106-S19-111. PubMed ID: 9427279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New treatment for ovarian cancer poses ecology dilemma.
    Crumbie A
    Nurs Times; 1994 Jun 15-21; 90(24):34-5. PubMed ID: 7913219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenomics of paclitaxel.
    Rodríguez-Antona C
    Pharmacogenomics; 2010 May; 11(5):621-3. PubMed ID: 20415548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rewiring cellular metabolism for heterologous biosynthesis of Taxol.
    Nazhand A; Durazzo A; Lucarini M; Mobilia MA; Omri B; Santini A
    Nat Prod Res; 2020 Jan; 34(1):110-121. PubMed ID: 31298589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Research progress on the source, production, and anti-cancer mechanisms of paclitaxel.
    Yang YH; Mao JW; Tan XL
    Chin J Nat Med; 2020 Dec; 18(12):890-897. PubMed ID: 33357719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs.
    Khanna C; Rosenberg M; Vail DM
    J Vet Intern Med; 2015; 29(4):1006-12. PubMed ID: 26179168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy.
    Sharifi-Rad J; Quispe C; Patra JK; Singh YD; Panda MK; Das G; Adetunji CO; Michael OS; Sytar O; Polito L; Živković J; Cruz-Martins N; Klimek-Szczykutowicz M; Ekiert H; Choudhary MI; Ayatollahi SA; Tynybekov B; Kobarfard F; Muntean AC; Grozea I; Daştan SD; Butnariu M; Szopa A; Calina D
    Oxid Med Cell Longev; 2021; 2021():3687700. PubMed ID: 34707776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paclitaxel: biosynthesis, production and future prospects.
    Howat S; Park B; Oh IS; Jin YW; Lee EK; Loake GJ
    N Biotechnol; 2014 May; 31(3):242-5. PubMed ID: 24614567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An overview of experience with TAXOL (paclitaxel) in the U.S.A.
    Donehower RC; Rowinsky EK
    Cancer Treat Rev; 1993; 19 Suppl C():63-78. PubMed ID: 8106155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current issues in the chemotherapy of malignant tumors. Taxol (paclitaxel), Taxoter].
    Gorbunova VA; Garin AM; Tiuliandin SA; Orel NF; Roshchin EM; Voĭnarevich OA
    Vopr Onkol; 1994; 40(7-12):259-66. PubMed ID: 7610618
    [No Abstract]   [Full Text] [Related]  

  • 51. Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives.
    Scripture CD; Figg WD; Sparreboom A
    Curr Neuropharmacol; 2006 Apr; 4(2):165-72. PubMed ID: 18615126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update.
    Ahmed Khalil A; Rauf A; Alhumaydhi FA; Aljohani ASM; Javed MS; Khan MA; Khan IA; El-Esawi MA; Bawazeer S; Bouyahya A; Rebezov M; Shariati MA; Thiruvengadam M
    Curr Pharm Des; 2022; 28(41):3363-3373. PubMed ID: 36330627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trials and progress with paclitaxel in ovarian cancer.
    Kumar S; Mahdi H; Bryant C; Shah JP; Garg G; Munkarah A
    Int J Womens Health; 2010 Nov; 2():411-27. PubMed ID: 21270965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Taxol: biosynthesis, molecular genetics, and biotechnological applications.
    Jennewein S; Croteau R
    Appl Microbiol Biotechnol; 2001 Oct; 57(1-2):13-9. PubMed ID: 11693909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress in research on paclitaxel and tumor immunotherapy.
    Zhu L; Chen L
    Cell Mol Biol Lett; 2019; 24():40. PubMed ID: 31223315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of the sexual stage of Pestalotiopsis microspora, a taxol-producing fungus.
    Metz AM; Haddad A; Worapong J; Long DM; Ford EJ; Hess WM; Strobel GA
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():2079-2089. PubMed ID: 10931912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absolute Configuration Determination of a Taxol Precursor Based on Raman Optical Activity Spectra.
    Profant V; Jegorov A; Bouř P; Baumruk V
    J Phys Chem B; 2017 Feb; 121(7):1544-1551. PubMed ID: 28110523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Docetaxel-induced Scleroderma in A Breast Cancer Patient: A Case Report.
    Kılıç MÖ; Yalaza M; Bilgiç Cİ; Dener C
    J Breast Health; 2015 Apr; 11(2):95-97. PubMed ID: 28331700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel.
    Zhang S; Ye T; Liu Y; Hou G; Wang Q; Zhao F; Li F; Meng Q
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paclitaxel.
    Alqahtani FY; Aleanizy FS; El Tahir E; Alkahtani HM; AlQuadeib BT
    Profiles Drug Subst Excip Relat Methodol; 2019; 44():205-238. PubMed ID: 31029218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.